TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the voting results from its Annual General Meeting held on June 20, 2016 in Toronto, Ontario. The total number of shares represented in person or by proxy at the meeting was 126,757,709, representing 59.48% of the total issued and outstanding Acerus shares.